Published in Acta Psychiatr Scand on January 01, 2007
Toward the delineation of mania subtypes in the French National EPIMAN-II Mille Cohort. Comparisons with prior cluster analytic investigations. Eur Arch Psychiatry Clin Neurosci (2008) 0.76
Respective potencies of Botox and Dysport: a double blind, randomised, crossover study in cervical dystonia. J Neurol Neurosurg Psychiatry (2002) 2.66
Systematic clinical methodology for validating bipolar-II disorder: data in mid-stream from a French national multi-site study (EPIDEP). J Affect Disord (1998) 1.66
Loss as a determinant of PTSD in a cohort of adult survivors of the 1988 earthquake in Armenia: implications for policy. Acta Psychiatr Scand (2000) 1.60
Further distinctions between manic-depressive illness (bipolar disorder) and primary depressive disorder (unipolar depression) Am J Psychiatry (1993) 1.52
The treatment of negative symptoms and deficit states of chronic schizophrenia: olanzapine compared to amisulpride and placebo in a 6-month double-blind controlled clinical trial. Acta Psychiatr Scand (2006) 1.50
[New medical device hospital assessment: what kind of clinical data?]. Ann Pharm Fr (2012) 1.38
Importance of psychotic features to long-term course in major depressive disorder. Am J Psychiatry (1996) 1.33
Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord (2010) 1.27
Cyclothymic temperament as a prospective predictor of bipolarity and suicidality in children and adolescents with major depressive disorder. J Affect Disord (2005) 1.22
Prognostic effect of the variable course of alcoholism on the 10-year course of depression. Am J Psychiatry (1994) 1.21
Association between major depressive disorder and physical illness. Psychol Med (1993) 1.13
Long-term prognosis of bipolar I disorder. Acta Psychiatr Scand (1999) 1.06
[Modern typology of symptoms and obsessive-compulsive syndromes: results of a large French study of 615 patients]. Encephale (1996) 1.04
Three-dimensional structure of the Hospital Anxiety and Depression Scale in a large French primary care population suffering from major depression. Psychiatry Res (2001) 1.02
Toward a refined phenomenology of mania: combining clinician-assessment and self-report in the French EPIMAN study. J Affect Disord (2001) 1.02
Gender, temperament, and the clinical picture in dysphoric mixed mania: findings from a French national study (EPIMAN). J Affect Disord (1998) 1.02
A prospective follow-up of patients with bipolar and primary unipolar affective disorder. Arch Gen Psychiatry (1993) 0.99
Polarity sequence, depression, and chronicity in bipolar I disorder. J Nerv Ment Dis (1999) 0.99
Suicidal behaviour in a French Cohort of major depressive patients: characteristics of attempters and nonattempters. J Affect Disord (2009) 0.98
Stable trait components of hopelessness: baseline and sensitivity to depression. J Abnorm Psychol (1996) 0.97
Clinical and psychometric characterization of depression in mixed mania: a report from the French National Cohort of 1090 manic patients. J Affect Disord (2006) 0.97
Cyclothymic OCD: a distinct form? J Affect Disord (2003) 0.94
Validating affective temperaments in their subaffective and socially positive attributes: psychometric, clinical and familial data from a French national study. J Affect Disord (2005) 0.94
Breast-conserving surgery with or without radiotherapy vs mastectomy for ductal carcinoma in situ: French Survey experience. Br J Cancer (2009) 0.93
Obsessive-compulsive disorder: a clinical, neuropsychological and positron emission tomography study. Acta Psychiatr Scand (1990) 0.91
[Frequency and clinical aspects of bipolar II disorder in a French multicenter study: EPIDEP]. Encephale (2001) 0.88
Characteristics and significance of untreated major depressive disorder. Am J Psychiatry (1995) 0.88
[Bipolar obsessive-compulsive disorder: confirmation of results of the "ABC-OCD" survey in 2 populations of patient members versus non-members of an association]. Encephale (2002) 0.88
Familial alcoholism in manic-depressive (bipolar) disease. Am J Med Genet (1996) 0.87
Catecholamines metabolism in infantile autism: a controlled study of 22 autistic children. J Autism Dev Disord (1987) 0.86
The feasibility of self-assessment of dysphoric mania in the French national EPIMAN study. J Affect Disord (2001) 0.86
[Comparative double-blind study of bromazepam versus prazepam in non-psychotic anxiety]. Encephale (1994) 0.86
Alcoholism and drug abuse in three groups--bipolar I, unipolars and their acquaintances. J Affect Disord (1998) 0.86
[Herpetic stomatitis-gingivitis in children: controlled trial of acyclovir versus placebo]. Ann Pediatr (Paris) (1988) 0.85
Salt or no salt in the treatment of cirrhotic ascites: a randomised study. Gut (1986) 0.84
Mood stabilizer augmentation in apparently "unipolar" MDD: predictors of response in the naturalistic French national EPIDEP study. J Affect Disord (2005) 0.84
Hyperthymic temperament may protect against suicidal ideation. J Affect Disord (2010) 0.83
Dysthymia: clinical picture, extent of overlap with chronic fatigue syndrome, neuropharmacological considerations, and new therapeutic vistas. J Affect Disord (1999) 0.83
Family history and symptom levels during treatment for bipolar I affective disorder. Biol Psychiatry (2000) 0.82
Delineating psychopathologic clusters within dysthymia: a study of 512 out-patients without major depression. J Affect Disord (1999) 0.82
The role of drug and alcohol abuse in recent increases in depression in the US. Psychol Med (1996) 0.82
Adjunctive dopamine agonists in treatment-resistant bipolar II depression: an open case series. Pharmacopsychiatry (2001) 0.82
[The Pleasure-Displeasure Scale. Use in the evaluation of depressive illness]. Encephale (1987) 0.81
Temperament and job stress in Japanese company employees. J Affect Disord (2005) 0.80
The Italian version of the validated short TEMPS-A: the temperament evaluation of Memphis, Pisa, Paris and San Diego. J Affect Disord (2010) 0.79
[Retardation in depressive states : elaboration of a quantitative rating scale (author's transl)]. Encephale (1980) 0.79
Validating the soft bipolar spectrum in the French National EPIDEP Study: the prominence of BP-II 1/2. J Affect Disord (2006) 0.79
Process of adaptation to Spanish of the Temperament Evaluation of Memphis, Pisa, Paris and San Diego Scale. Self applied version (TEMPS-A). Actas Esp Psiquiatr (2005) 0.79
Familial depression versus depression identified in a control group: are they the same? Psychol Med (1995) 0.78
[Methadone: from pharmacokinetic profile to clinical pharmacology]. Encephale (2006) 0.78
Excessive checking for non-anxiogenic stimuli in obsessive-compulsive disorder. Eur Psychiatry (2012) 0.78
Baseline and prodromal characteristics of first- versus multiple-episode mania in a French cohort of bipolar patients. Eur Psychiatry (2011) 0.78
[Factor structure of the H.S.C.L. in a sample of French anxious-depressed patients]. Ann Med Psychol (Paris) (1984) 0.78
[Prevalence of obsessive-compulsive disorders in a large French patient population in psychiatric consultation]. Encephale (1996) 0.78
Plasma melatonin and cortisol in patients with obsessive-compulsive disorder: relationship with axillary temperature, physical activity, and clinical symptoms. Biol Psychiatry (1998) 0.78
Religious involvement in major depression: protective or risky behavior? The relevance of bipolar spectrum. J Affect Disord (2013) 0.77
[Pain in the elderly. A study of 183 consecutive subjects hospitalized in a geriatric medical ward]. Presse Med (1999) 0.77
Rating scale for the assessment of communication disorders in schizophrenics. Eur Psychiatry (1997) 0.77
Psychosensorial and related phenomena in panic disorder and in temporal lobe epilepsy. Compr Psychiatry (1996) 0.77
Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Pharmacopsychiatry (1999) 0.77
[Ductal carcinoma in situ of the breast (DCIS). Histopathological features and treatment modalities: analysis of 1,289 cases]. Bull Cancer (2010) 0.77
"Folie circulaire" vs "Folie à double forme": contribution from a French national study. Eur Psychiatry (2010) 0.77
Plasma lipoprotein distribution and lipid transfer activities in patients with type IIb hyperlipidemia treated with simvastatin. Atherosclerosis (1999) 0.77
[Minimizing the risks associated with QTc prolongation in people with schizophrenia. A consensus statement by the Cardiac Safety in Schizophrenia Group]. Encephale (2002) 0.76
[Metabolism of serotonin in autism in children]. Encephale (1989) 0.76
[The study of the efficacy of fluoxetine versus tianeptine in the treatment of elderly depressed patients followed in general practice]. Encephale (1999) 0.76
Patterns of prescription of four major antipsychotics: a retrospective study based on medical records of psychiatric inpatients. Pharmacoepidemiol Drug Saf (2005) 0.76
Psychopharmacological profile of the new cognition enhancing agent exifone in the mouse. Arzneimittelforschung (1987) 0.76
[Prospective follow-up over a 12 month period of a cohort of 155 patients with obsessive-compulsive disorder: phase III National DRT-TOC Study]. Encephale (2001) 0.76
[Validation of M. Weissman's social adaptation questionnaire in its French version]. Ann Med Psychol (Paris) (1995) 0.76
[Repeat evaluation of impulsiveness in a cohort of 155 patients with obsessive-compulsive disorder: 12 months prospective follow-up]. Encephale (1997) 0.76
Determination of the optimal dosage regimen of captopril + hydrochlorothiazide in the treatment of moderate arterial hypertension. Br J Clin Pharmacol (1987) 0.75
Secular trends in lifetime onset of MDD stratified by selected sociodemographic risk factors. J Psychiatr Res (1993) 0.75
Diflunisal versus placebo for treatment of pain in general practice. Clin Ther (1982) 0.75
[Existence of asymptomatic changes in left ventricular function in the diabetic. Noninvasive study]. Rev Med Interne (1985) 0.75
[Fibrinogen and pentoxifylline. Results of a French cooperative exploratory study of stage II arteritis]. J Mal Vasc (1989) 0.75
[Effect of antidepressant treatment on sense of dyscontrol: preliminary studies]. Encephale (1995) 0.75
[Erection disorders: efficacy and tolerability after 6 months of intracavernous self-injections of alprostadil. Groupe Français d'Etude de l'Alprostadil]. Presse Med (1994) 0.75
Fibrinogen and pentoxifylline. Thromb Res (1989) 0.75
[Disorders of catecholamine metabolism in infantile autism. Comparative study of 22 autistic children]. Encephale (1989) 0.75
[Major agitated-anxious versus blunted-retarded depression: differential effects of fluoxetine]. Encephale (1995) 0.75
[Clonidine versus a placebo trial in manic disorder]. Encephale (1990) 0.75
5D.01: DECREASE IN EXCESS SALT CONSUMPTION FOR HYPERTENSIVE SUBJECTS LIVING IN THE PARIS AREA. J Hypertens (2015) 0.75
[Why a new population, why a new scale. Definition and measurement of a new syndrome: neurobiological deficit in individuals over 50 years of age]. Rev Prat (1988) 0.75
[Double-blind study of the efficacy of an antiserotoninergic drug, pizotifen, in Duchenne's muscular dystrophy]. Arch Fr Pediatr (1987) 0.75
[A controlled double-blind study of tetrabamate versus lorazepam and placebo in generalized anxiety]. Encephale (1992) 0.75
[Widlöcher's depression scale. Examination of a sample of nondepressed, nondejected subjects. II]. Ann Med Psychol (Paris) (1983) 0.75